SNAREopathy in Neurologic Disorders: From Synaptic Mechanisms to Genetic and Epigenetic Regulation

Besin, Valentinus and Mulyanata, Lisa Thalia and Humardani, Farizky Martriano (2026) SNAREopathy in Neurologic Disorders: From Synaptic Mechanisms to Genetic and Epigenetic Regulation. The Neuroscientist. pp. 1-12. ISSN 1089-4098

[thumbnail of abstrak.pdf] PDF
abstrak.pdf

Download (88kB)
[thumbnail of besin-et-al-2026-snareopathy-in-neurologic-disorders-from-synaptic-mechanisms-to-genetic-and-epigenetic-regulation.pdf] PDF
besin-et-al-2026-snareopathy-in-neurologic-disorders-from-synaptic-mechanisms-to-genetic-and-epigenetic-regulation.pdf
Restricted to Repository staff only

Download (1MB) | Request a copy
Official URL / DOI: https://doi.org/10.1177/1073858426146353

Abstract

Abstract Synaptic dysfunction is a central feature of many neurologic diseases, and the soluble N-ethylmaleimide–sensitive factor attachment protein receptor (SNARE) complex plays a critical role in regulating synaptic vesicle fusion and neurotransmitter release. Despite the rapidly growing body of research on SNAREs, comprehensive reviews addressing their mechanisms, as well as the influence of genetic variants and epigenetic regulation, remain limited. This review aims to address this gap. Disruption of SNARE processes can impair synaptic signaling and lead to neurologic pathology. Genetic variants in SNARE-related genes, including VAMP2, STX1A/STX1B, SNAP-25, STXBP1, UNC13A, SYT1, RIM, and RAB3, have been associated with a broad spectrum of neurologic conditions. In addition to genetic variants, emerging evidence indicates that epigenetic mechanisms can regulate the function of SNARE-related genes in physiologic processes and contribute to disease pathogenesis. Genetic variants are increasingly used as diagnostic markers and may inform the development of targeted therapeutic strategies, whereas epigenetic signatures hold promise as diagnostic, prognostic, and treatment-monitoring biomarkers. Although clinical applications remain limited, advancing knowledge of SNARE genetics and epigenetics may facilitate the development of novel diagnostic modalities, prognostic tools, and precision therapeutic strategies for neurologic diseases.

Item Type: Article
Uncontrolled Keywords: SNARE, neurotransmitter release, SNAREopathy, neurologic disorders, genetic variant, epigenetic
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medical
Depositing User: BAMBANG SEPTIAWAN
Date Deposited: 14 Jul 2026 01:43
Last Modified: 14 Jul 2026 01:43
URI: http://repository.ubaya.ac.id/id/eprint/50957

Actions (login required)

View Item View Item